Illumina, Inc. (NAS: ILMN) Stock Analysis & Fundamentals

ILMNIllumina, Inc.

NAS · US · Healthcare · Diagnostics & Research · illumina.com

187.15USD-2.12%Mkt Cap: 28.32B $P/E: 33.971d ago

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and arr…

Headline	Source	Time
This week
Alamar Hits A High Note On Alzheimer's Buzz If you’re an Alamar Biosciences (ALMR) shareholder, Friday was a good day. The stock climbed +7.3%, closing the session at a new 52-week high of $28.42. That’s a tidy gain on a day when the S&P 500 barely nudged up +0.4% and some key industry peers actually lost ground.	Trefis	Jul 13
Cathie Wood Loads Up on SpaceX, Meta, Eli Lilly and Circle Group	GuruFocus.com	Jul 13
Jeff Bezos Backed Grail Before It Lost Half Its Value. Here's Whether He Was Early -- or Just Wrong.	Motley Fool	Jul 13
Older
Zacks Investment Ideas feature highlights: XLV, XBI, LLY, EXEL, PTCT, FTRE and ILMN	Zacks	Jul 10
Illumina (ILMN) Is Up 6.87% in One Week: What You Should Know	Zacks	Jul 9
Illumina Stock Gains 43.7% in 2026: What's Powering the Rally?	Zacks	Jul 9
2 Mooning Stocks Worth Investigating and 1 We Avoid	StockStory	Jul 9
Illumina (ILMN) Stock May Be 27% Undervalued Following Strong Q1 Results	Simply Wall St.	Jul 8
Illumina (ILMN) Jumps On Earnings And Guidance As Valuation Questions Remain	Simply Wall St.	Jul 8
Illumina (ILMN) Is Up 9.1% After Raising EPS Outlook On Revenue Beat Has The Bull Case Changed?	Simply Wall St.	Jul 8
EXEL vs. ILMN: Which Stock Should Value Investors Buy Now?	Zacks	Jul 8
Illumina, Inc. (ILMN) Hit a 52 Week High, Can the Run Continue?	Zacks	Jul 8
Illumina (ILMN) Lifts Full Year EPS Outlook After Revenue Beat	Simply Wall St.	Jul 8
Life Sciences Tools & Services Stocks Q1 Results: Benchmarking Illumina (NASDAQ:ILMN)	StockStory	Jul 7
What's Fueling Omnicell Stock's 52.6% Rally Over the Past Year?	Zacks	Jul 7
Does TNDM Stock Still Deserve a Place in Your Portfolio?	Zacks	Jul 7
Is C4 Therapeutics (CCCC) Stock Outpacing Its Medical Peers This Year?	Zacks	Jul 7
1 High-Flying Stock with Solid Fundamentals and 2 We Find Risky	StockStory	Jul 6
Should You Continue to Hold ILMN Stock in Your Portfolio?	Zacks	Jul 3
Prediction: Grail Stock Will Skyrocket to $100 in 1 Year	Motley Fool	Jul 2
3 Mid-Cap Stocks That Concern Us	StockStory	Jul 2
SkylineDx’s Merlin CP-GEP Granted FDA Breakthrough Device Designation	Exec Edge	Jul 1
Illumina (ILMN) Gets Bernstein’s Market Perform Rating Amid NovaSeq X Recovery	Insider Monkey	Jul 1
AZN vs. ILMN: Which Stock Should Value Investors Buy Now?	Zacks	Jul 1
Why Illumina (ILMN) Stock Is Down Today	StockStory	Jun 30
Roche takes on Illumina with new NGS system	MedTech Dive	Jun 30
Why Illumina (ILMN) Stock Is Trading Up Today	StockStory	Jun 24
Illumina (ILMN) Stock After 80% One-Year Rebound Is The Price Now Justified	Simply Wall St.	Jun 24
Adding Eli Lilly’s R&D Chief to the Board Might Change The Case For Investing In Illumina (ILMN)	Simply Wall St.	Jun 24
1 Unpopular Stock That Deserves Some Love and 2 Facing Challenges	StockStory	Jun 16
Stocks Settle Sharply Lower on Escalating Middle East Tensions	Barchart	Jun 10
Illumina upgraded to overweight at JPMorgan on clinical demand outlook	Investing.com	Jun 10
Stocks Resume Decline as Chipmakers and AI Companies Fall	Barchart	Jun 10
Stocks Fall on Weakness in Tech and Trucking Companies	Barchart	Jun 10
Nike downgraded, Oscar Health upgraded: Wall Street's top analyst calls	The Fly	Jun 10
Nasdaq Futures Plunge as Tech Selloff Deepens, U.S. Inflation Data in Focus	Barchart	Jun 10
Samsung Electronics invests $175 million in Element Biosciences' Series E funding round	Reuters	Jun 9
Samsung Elec invests $175 million to become top shareholder in US genetics firm	Reuters	Jun 9
Illumina (ILMN) Valuation Check After New Oncology Collaborations And MRD Research Launch	Simply Wall St.	Jun 7
Recursion Pharmaceuticals (RXRX) Up 16.2% Since Last Earnings Report: Can It Continue?	Zacks	Jun 5
Is Grail Stock a Bad-News Buy After Its Recent Pullback?	Motley Fool	Jun 4
Why Is Editas (EDIT) Down 12.4% Since Last Earnings Report?	Zacks	Jun 4
Honeywell Stock Is Likely to Reward Shareholders Following Quantinuum IPO, Split	Barchart	Jun 4
Is Illumina’s (ILMN) Deeper IDT DRAGEN Tie-Up Quietly Rewriting Its Oncology Software Edge?	Simply Wall St.	Jun 3
BioMarin (BMRN) Up 0.2% Since Last Earnings Report: Can It Continue?	Zacks	Jun 3
ILMN Stock Jumps 98.7% in a Year: What's Powering the Surge?	Zacks	Jun 3
3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2026	Zacks	Jun 2
GRAIL, Inc. (GRAL): One of the Best Stock Picks of Jeff Bezos	Insider Monkey	Jun 1
1 Cash-Producing Stock Worth Investigating and 2 We Question	StockStory	Jun 1
Illumina Oncology Launches Put Product Depth Against Rapid Share Price Gains	Simply Wall St.	May 30

Industry Peers